The drug discovery and development process is having a casting call for cutting-edge technology to star in its much anticipated reboot. Companies are now tapping into the power of AI and ML to speed up the bench to bedside journey, alleviate some of the clinical barriers to the drug development process, and make clinical trials more equitable. How can technology further expedite the sharing of research data across different health systems? Peel back the curtain on the breakthroughs in real world evidence and real word data in clinical trials, more direct-to-patient accessibility and how technology can be leveraged to simplify and reboot the drug development pipeline.